As the global population ages, eye-related diseases such as cataracts, age-related macular degeneration, and glaucoma are becoming more prevalent. For seniors, maintaining eye health is critical to preserving independence and quality of life. However, many treatments for these conditions can be difficult to administer and come with challenges such as discomfort or poor compliance.
Our specialized approach focuses on realigning existing medications to create more targeted, effective treatments tailored specifically to the needs of the elderly. By refining dosage forms and developing user-friendly delivery methods, we aim to make medication more accessible and manageable for aging patients. With this approach, we seek to reduce the burden on healthcare resources while enhancing the ocular health and well-being of older individuals.
